Evaluation of the Incidence of Endophthalmitis after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor-Reference-Cited by-同舟云学术

Evaluation of the Incidence of Endophthalmitis after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor

Published:2011 Issue:3 Volume:226 Page:145-150
ISSN:1423-0267
Container-title:Ophthalmologica
language:en
Short-container-title:Ophthalmologica

Author:

Inoue Maiko,Kobayakawa Shinichiro,Sotozono Chie,Komori Hideki,Tanaka Kumiko,Suda Yuzo,Matsushima Hiroyuki,Kinoshita Shigeru,Senoo Tadashi,Tochikubo Tetsuo,Kadonosono Kazuaki

Publisher

S. Karger AG

Subject

Sensory Systems,Ophthalmology,General Medicine

Reference32 articles.

1. Ranibizumab for Neovascular Age-Related Macular Degeneration

2. Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration

3. Pegaptanib for Neovascular Age-Related Macular Degeneration

4. INTRAVITREAL BEVACIZUMAB (AVASTIN) THERAPY FOR PERSISTENT DIFFUSE DIABETIC MACULAR EDEMA

5. A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti–Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular Edema

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. POSTINTRAVITREAL INJECTION AND POSTCATARACT EXTRACTION ENDOPHTHALMITIS VISUAL OUTCOMES BY ORGANISM;Retina;2024-09

2. Recurrence Rate during 5-Year Period after Suspension of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration;Journal of Clinical Medicine;2024-07-24

3. Incidence and Visual Outcomes of Endophthalmitis After Intravitreal Injection of Dexamethasone Implant vs Ranibizumab;Journal of VitreoRetinal Diseases;2022-08-25

4. Outcomes of three intravitreal injections of bevacizumab given monthly for diabetic macular oedema is a viable treatment for an economically disadvantaged population;African Vision and Eye Health;2021-04-28

5. Enterococcus faecalis Endophthalmitis: Clinical Settings, Antibiotic Susceptibility, and Management Outcomes;Microorganisms;2021-04-24